Cassava Sciences Inc (SAVA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.35
• Market Cap: $142.03M
• EPS: $-2.22
• 52-Week High: $4.98
• 52-Week Low: $1.15

Market Sentiment

Cassava Sciences Inc currently has a Bullish sentiment score of 0.37.

About Cassava Sciences Inc

Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas, dedicated to pioneering innovative therapies for neurodegenerative diseases, with a primary focus on Alzheimer's disease. The company is advancing its lead candidate, simufilam, through late-stage clinical trials to establish its potential effectiveness and safety. By addressing critical unmet medical needs in neurology, Cassava aims to transform the treatment landscape for neurodegenerative disorders, po...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cassava Sciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SAVA pay dividends?

Cassava Sciences Inc (SAVA) does not currently pay a regular dividend.

What is SAVA's market cap?

Cassava Sciences Inc (SAVA) has a market capitalization of $142.03M with a current stock price of $2.35.